TSHA
#2050
Taysha Gene Therapies, Inc. - Common Stock
5.6 9 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.39%
Variación mensual
-3.40%
Variación en los últimos 6 meses
+27.87%
Cambio anual
+96.21%
Cierres anteriores
5.7 7
Open
5.6 9
Mínimo
5.6 9
Máximo
5.6 9
Volumen
98
Financials
- Market Capitalization 1.85 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.21
Relación precio/flujo de caja
396.94
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2018 |  NBTX Nanobiotix S.A. - ADSs | 40.64 USD | -1.43% | +1.27% | +8.17% | +390.23% | 1.97 B USD | ||
| 2048 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.32 USD | -0.82% | -0.49% | +7.46% | +8.48% | 1.87 B USD | ||
| 2052 |  VIR Vir Biotechnology, Inc. - Common Stock | 10.94 USD | +1.02% | +9.07% | +25.17% | +82.94% | 1.85 B USD | ||
| 2068 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD |